Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome Across Different Traditional Chinese Medicine Syndrome Types.
- 1Shenzhen School of Clinical Medicine, Southern Medical University, Shenzhen 518000, China.
- 2Dongguan Hospital of Guangzhou University of Chinese Medicine (Dongguan Hospital of Traditional Chinese Medicine), Dongguan 523000, China.
- 3The People's Hospital of Baoan Shenzhen, Shenzhen 518000, China.
Abstract
Background
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women of reproductive age, and accumulating evidence suggests that gut microbiota dysbiosis plays an important role in its pathogenesis, although microbiota characteristics across different Traditional Chinese medicine (TCM) syndrome types remain poorly understood.Objective
This study aimed to analyze the structural differences in intestinal microbiota between patients with PCOS and healthy women. It also sought to characterize the fecal microbiota features across three distinct PCOS subgroups based on TCM syndrome differentiation.Materials and methods
A total of 107 newly diagnosed PCOS patients and 23 healthy controls were recruited. The PCOS cohort was subdivided according to TCM syndromes into liver meridian depression and fire (n=34), spleen deficiency and phlegm-dampness (n=41), and kidney deficiency and blood stasis (n=32). Fecal samples were analyzed by sequencing the V3-V4 regions of the bacterial 16S rDNA gene to assess variations in bacterial species, diversity, and structure.Results
Significant differences in gut microbiota were observed. β-diversity indicated greater differences in gut microbial community composition in all PCOS subgroups compared to healthy controls, while α-diversity varied among the TCM subgroups. At the phylum level, Actinobacteria and Cyanobacteria abundances varied across the groups. At the genus level, the PCOS group showed elevated Megamonas. At the species level, Faecalibacterium prausnitzii was lower in the spleen deficiency and phlegm-dampness group, whereas Bacteroides uniformis was more abundant in healthy controls. Functional analysis indicated that differences were primarily related to bacterial metabolism and antibiotic synthesis.Conclusions
The characteristics of intestinal microbiota vary among PCOS patients with different TCM syndrome types. This finding provides a basis for developing more precise diagnosis and treatment strategies for PCOS within the TCM framework.
Related
- Characteristics of Microbiota in Different Segments of the Digestive Tract of Orange‐Collared Keelback ( Rhabdophis himalayanus )
- Microbiota–host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicine
- Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer
- Evaluating traditional Chinese medicine modulation of the gut microbiota–bile acid axis in metabolic and inflammatory diseases: mechanistic evidence and translational priorities
- Modulation of microbiota by traditional Chinese medicine in chronic inflammatory airway disease: a systematic review and meta-analysis of animal studies
BibTeX
@article{li2026characteristics,
title = {{Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome Across Different Traditional Chinese Medicine Syndrome Types.}},
author = {Hanqiu Li and Weiru Peng and Xuemei Huang and Huixian Lv and Jianhui Chen and Xiaobing Chen and Yixi Feng and Yuzhong Xu},
journal = {Iranian journal of biotechnology},
year = {2026},
month = oct,
doi = {10.30498/ijb.2026.566118.4335},
url = {https://europepmc.org/article/MED/42928833},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome Across Different Traditional Chinese Medicine Syndrome Types.
AU - Hanqiu Li
AU - Weiru Peng
AU - Xuemei Huang
AU - Huixian Lv
AU - Jianhui Chen
AU - Xiaobing Chen
AU - Yixi Feng
AU - Yuzhong Xu
PY - 2026
DA - 2026/10/01
JO - Iranian journal of biotechnology
DO - 10.30498/ijb.2026.566118.4335
UR - https://europepmc.org/article/MED/42928833
AB - Background Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women of reproductive age, and accumulating evidence suggests that gut microbiota dysbiosis plays an important role in its pathogenesis, although microbiota characteristics across different Traditional Chinese medicine (TCM) syndrome types remain poorly understood.Objective This study aimed to analyze the structural differences in intestinal microbiota between patients with PCOS and healthy women. It also sought to characterize the fecal microbiota features across three distinct PCOS subgroups based on TCM syndrome differentiation.Materials and methods A total of 107 newly diagnosed PCOS patients and 23 healthy controls were recruited. The PCOS cohort was subdivided according to TCM syndromes into liver meridian depression and fire (n=34), spleen deficiency and phlegm-dampness (n=41), and kidney deficiency and blood stasis (n=32). Fecal samples were analyzed by sequencing the V3-V4 regions of the bacterial 16S rDNA gene to assess variations in bacterial species, diversity, and structure.Results Significant differences in gut microbiota were observed. β-diversity indicated greater differences in gut microbial community composition in all PCOS subgroups compared to healthy controls, while α-diversity varied among the TCM subgroups. At the phylum level, Actinobacteria and Cyanobacteria abundances varied across the groups. At the genus level, the PCOS group showed elevated Megamonas. At the species level, Faecalibacterium prausnitzii was lower in the spleen deficiency and phlegm-dampness group, whereas Bacteroides uniformis was more abundant in healthy controls. Functional analysis indicated that differences were primarily related to bacterial metabolism and antibiotic synthesis.Conclusions The characteristics of intestinal microbiota vary among PCOS patients with different TCM syndrome types. This finding provides a basis for developing more precise diagnosis and treatment strategies for PCOS within the TCM framework.
SN - 1728-3043
SN - 2322-2921
ER -